The AMHR2 Gene Persistent Mullerian Duct Syndrome Type 2 Genetic Test is a specialized diagnostic examination conducted to identify mutations in the AMHR2 gene, which are associated with Persistent Mullerian Duct Syndrome (PMDS) type 2. PMDS is a rare disorder affecting male sexual development, where individuals with typically male chromosomes (46,XY) and male external genitalia also retain female reproductive structures, such as a uterus and fallopian tubes, due to a failure of the Mullerian ducts to regress during fetal development. This condition is attributed to mutations in the AMHR2 gene, which plays a critical role in this regression process.
The test is available at DNA Labs UAE, a reputable facility known for its advanced genetic testing services. The cost of the test is set at 4400 AED, offering a comprehensive analysis for those who suspect they might have or are carriers of this condition. The results from this test can provide essential information for diagnosis, management, and genetic counseling, helping affected individuals and their families understand the implications of PMDS and plan for any necessary medical interventions or support.
The CORIN Gene Preeclampsia Type 5 Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to assess the risk of developing preeclampsia, a potentially serious condition that affects some women during pregnancy. Preeclampsia is characterized by high blood pressure and often a significant amount of protein in the urine. The condition can lead to severe complications for both the mother and the unborn child if left unchecked.
This genetic test specifically focuses on mutations in the CORIN gene, which have been associated with an increased risk of developing preeclampsia. The CORIN gene plays a crucial role in the regulation of blood pressure, and mutations in this gene can disrupt normal blood pressure regulation during pregnancy, leading to preeclampsia.
Offered at a cost of 4400 AED, the test involves collecting a DNA sample from the patient, usually through a blood draw or a cheek swab. The sample is then analyzed in the laboratory to identify any genetic variations in the CORIN gene that may increase the risk of preeclampsia.
This test is particularly valuable for women with a personal or family history of preeclampsia, as it can provide important information that may influence pregnancy management and monitoring strategies. By identifying at-risk individuals early, it is possible to implement preventive measures and close monitoring to mitigate the risks associated with preeclampsia.
The C4BPA gene, associated with the complement system of the immune response, has been identified as a potential factor in recurrent pregnancy loss (RPL). The genetic test for C4BPA-related pregnancy loss is a specialized diagnostic tool designed to identify mutations or anomalies in the C4BPA gene that could contribute to repeated miscarriages. This test is particularly relevant for individuals or couples who have experienced two or more unexplained pregnancy losses and are seeking answers and guidance for future pregnancies.
Conducted at DNA Labs UAE, a leading facility in genetic diagnostics and research, the test offers a comprehensive analysis of the C4BPA gene. The process involves collecting a DNA sample, typically through a blood draw, which is then analyzed using advanced genetic sequencing technologies to detect any variations in the C4BPA gene that may influence pregnancy outcomes.
The cost of the C4BPA gene pregnancy loss test at DNA Labs UAE is 4400 AED. This price includes the full testing process, from sample collection to the provision of a detailed report. The results from this test can provide invaluable insights for affected individuals, guiding them towards appropriate medical interventions or genetic counseling to address recurrent pregnancy loss and improve the chances of a successful future pregnancy.
The HSD17B3 gene is crucial in the development of male sexual characteristics, specifically in the conversion of androstenedione to testosterone, a key step in male hormone synthesis. Mutations in the HSD17B3 gene can lead to a rare form of pseudohermaphroditism, where an individual has male genetic makeup (46,XY) but develops female or ambiguous external genitalia due to the inability to produce enough testosterone during fetal development. This condition can also manifest with gynecomastia, which is the enlargement of breast tissue in males, during puberty when hormonal imbalances become more pronounced.
A genetic test focusing on the HSD17B3 gene can help in diagnosing this specific cause of pseudohermaphroditism with gynecomastia. This test is available at DNA Labs UAE, offering a comprehensive analysis to identify mutations in the HSD17B3 gene. Understanding these genetic underpinnings is crucial for proper management and treatment of affected individuals, guiding decisions regarding hormone therapy and surgical interventions.
The cost of the test is set at 4400 AED. It is a valuable investment for those seeking clarity on their diagnosis, enabling targeted treatment plans and providing essential information for family planning. The test is conducted with high precision and confidentiality, ensuring reliable results for patients and their families.
The SYCP3 gene, associated with Spermatogenic Failure 4 (SPGF4), is critical in the process of spermatogenesis, which is the production of sperm cells. Mutations in the SYCP3 gene can lead to male infertility, making it a significant focus for genetic testing in individuals or couples facing challenges in conceiving.
DNA Labs UAE offers a specialized genetic test targeting the SYCP3 gene to diagnose SPGF4. This test is particularly important for individuals with a suspected genetic basis for infertility, providing crucial information that can guide treatment decisions and reproductive planning.
The cost of the SYCP3 Gene SPGF4 Genetic Test at DNA Labs UAE is 4400 AED. The test involves collecting a DNA sample, usually through a blood draw or a cheek swab, which is then analyzed in the laboratory for any mutations in the SYCP3 gene. Results from this test can offer insights into the cause of infertility, helping healthcare providers recommend appropriate interventions or consider alternative reproductive options such as assisted reproductive technologies.
Given the complexity and sensitivity of genetic information, DNA Labs UAE ensures confidentiality and provides counseling to help individuals understand the test results and their implications. This comprehensive approach ensures that patients are supported throughout the diagnostic process.
The AURKC gene, also known as Aurora kinase C, plays a crucial role in the regulation of cell division, particularly during the meiotic phase of sperm production. Mutations in the AURKC gene can lead to male infertility issues, including spermatogenic failure 5 (SPGF5), a condition characterized by reduced sperm count or the absence of sperm in the semen, affecting a man's ability to father biological children.
The AURKC Gene SPGF5 Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the AURKC gene that are associated with spermatogenic failure. This test is crucial for men who have unexplained infertility issues, as it can provide a genetic explanation for their condition. Identifying the cause of infertility is the first step in exploring the appropriate fertility treatments or interventions.
The cost of the AURKC Gene SPGF5 Genetic Test at DNA Labs UAE is 4400 AED. This comprehensive test is performed in a state-of-the-art laboratory by skilled geneticists and laboratory technicians. The process involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed for specific mutations in the AURKC gene. Results from this test can offer valuable insights into treatment options, including the use of assisted reproductive technologies.
Choosing to undergo the AURKC Gene SPGF5 Genetic Test can be a significant step towards understanding and addressing infertility issues, offering couples hope and potential pathways to achieving their dreams of parenthood.
The SPATA16 gene, associated with Spermatogenic Failure 6 (SPGF6), plays a crucial role in male fertility. Mutations in this gene can lead to various reproductive issues, including reduced sperm count or quality, leading to infertility. The SPGF6 genetic test specifically targets the SPATA16 gene to identify any genetic abnormalities that might contribute to spermatogenic failure. This test is particularly valuable for individuals or couples facing unexplained infertility issues, providing them with crucial information that could guide their fertility treatments.
DNA Labs UAE offers this specialized genetic testing service. The test is priced at 4400 AED, providing a comprehensive analysis of the SPATA16 gene to assess the risk or presence of SPGF6. Conducted in a state-of-the-art laboratory setting by experienced geneticists, the test results can offer insightful data for both patients and healthcare providers, enabling a more tailored approach to fertility management and treatment strategies.
The CATSPER1 gene, also known as SPGF7, plays a critical role in male fertility, specifically in sperm motility and function. A genetic test for the CATSPER1 gene can provide crucial information for individuals or couples facing challenges with conception, helping to identify genetic factors that might be contributing to infertility issues.
DNA Labs UAE offers a comprehensive genetic test targeting the CATSPER1 gene, priced at 4400 AED. This test is designed to detect mutations or anomalies within the gene that could be impacting sperm performance, thus affecting fertility. Conducted in a state-of-the-art laboratory setting, the test requires a simple DNA sample, usually collected through a blood draw or a cheek swab.
Upon completion, the results from the CATSPER1 gene test can offer valuable insights for healthcare providers to develop personalized treatment plans or consider alternative reproductive options. This test is an essential tool for those seeking to understand the underlying genetic factors of infertility, providing a pathway towards informed decisions about family planning.
The NR5A1 Gene SPGF8 Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the NR5A1 gene, which have been linked to spermatogenic failure 8 (SPGF8). This condition is a significant factor contributing to male infertility, affecting the normal development and function of the reproductive cells. The NR5A1 gene plays a crucial role in the regulation of steroidogenic factor 1, impacting the development and function of the reproductive system in males.
Priced at 4400 AED, the test is conducted in the advanced facilities of DNA Labs UAE, employing cutting-edge genetic sequencing technologies to ensure accurate and reliable results. This test is particularly recommended for individuals or couples facing challenges with fertility, as it can provide vital insights into the genetic underpinnings of their condition. Early detection through the NR5A1 Gene SPGF8 Genetic Test can facilitate timely interventions and tailored treatment strategies, potentially improving the chances of conception.
DNA Labs UAE is renowned for its commitment to quality and precision in genetic testing, making it a trusted choice for patients seeking comprehensive genetic insights into their reproductive health.
The DPY19L2 gene SPGF9 genetic test is a specialized diagnostic assessment aimed at detecting mutations in the DPY19L2 gene, which is associated with globozoospermia, a rare condition that affects male fertility. This specific gene plays a crucial role in the proper formation of sperm heads, and mutations can lead to sperm abnormalities, significantly impacting an individual's ability to father biological children.
The test is conducted at DNA Labs UAE, a leading facility in genetic testing and analysis, ensuring high standards of accuracy and confidentiality. The process involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed for specific genetic alterations in the DPY19L2 gene.
Priced at 4400 AED, the test is an investment in understanding genetic factors that could influence reproductive health and planning. It provides valuable insights for individuals or couples facing challenges with fertility, guiding them towards appropriate treatment options or interventions. Given the complexity of genetic conditions affecting fertility, the DPY19L2 gene SPGF9 genetic test stands as a crucial tool in the realm of reproductive medicine and genetic counseling.
